Doctor discussion guide:

Similar documents
Doctor discussion guide:

Cholesterol. Medicines To Help You

Diseases & Conditions

CHOLESTEROL REDUCING MEDICATIONS. Five Main Categories. 1. Statins 2. Fibrates 3. Resins 4. Niacin 5. Cholesterol absorption inhibitor

PATIENT INFORMATION. Medicine To Treat: C ardiac Diseases. Lipid-Lowering Medicines. Statins Fibrates Fat Binding Agents Nicotinic Acid Group

Is patient?: Adult of any age with CVD risk factors; Female >50 or post-menopausal; Diagnosed CAD, PVD, TIA/ Stroke, Diabetes, CKD

High ( 50%) Restrictions mg 20-40mg PA; TS ⱡ 15 ⱡ

Dyslipidemia Management - Summary. Adults at any age with the following risk factors should be screened for lipids at any age:

A guide to cholesterol and heart disease for people with diabetes

STATIN UTILIZATION MANAGEMENT CRITERIA

Copy right protected Page 1

Diabetes Mellitus Type 2

Your cholesterol levels. Questions or concerns

Dyslipidemia Management. Cardiovascular disease (CVD) causes one third of deaths in Canada. (1) Due to an increase in diabetes, obesity

Evaluating statin drugs to treat: High Cholesterol and Heart Disease Comparing Effectiveness, Safety, and Price

University of Georgia Family & Consumer Sciences. Volume 27 Number 2 Spring 2013

ATP IV: Predicting Guideline Updates

How would you manage Ms. Gold

Simvastatin 40 mg equivalent

Common Drug Review Pharmacoeconomic Review Report

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia

Achieving Lipid Goals: 2008 Update. Laura Hansen, Pharm.D. Associate Professor, University of Colorado School of Pharmacy

Non-Statin Lipid-Lowering Agents M Holler - Last updated: 10/2016

> 130 > 130 (10-20% risk) <130 >160 (<10% risk) 0-1 Risk Factors <160 >160 >190

Hyperlipidemia: Past and Present. Rebecca Khaimova, PharmD The Brooklyn Hospital Center

( Diabetes mellitus, DM ) ( Hyperlipidemia ) ( Cardiovascular disease, CVD )

IMPORTANT: PLEASE READ

High ( 50%) Restrictions mg 20-40mg Simvastatin (Zocor) 10mg 20-40mg $1.66 Pravastatin (Pravachol) mg $6.

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008

MOLINA HEALTHCARE OF CALIFORNIA

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION LIPIDIL EZ. fenofibrate, NanoCrystal formulation tablets

Primary Care for Patients with HIV/AIDS What makes it different?

MY CHOLESTEROL GUIDE. Take Action. Live Healthy! heart.org/cholesterol

Hi Lipidaholics: This week case is a very common lipid disorder, but what are the medications needed to achieve goals of therapy.

Antihyperlipidemic Drugs

Antihyperlipidemic drugs

Information in these slides is used with permission from St. Mary s Cardiac Rehab

Conflicts of interest. What's the Skinny on the Lipid Guidelines? Key Differences. Are you applying the new ACC/AHA Lipid guidelines in your practice?

1. Diagnosis Table of Contents 1. Diagnosis a. Definition...5 b. Risk Factors...5 c. Screening...6 d. Signs and Symptoms...6 e. Testing and Evaluation

PART III: CONSUMER INFORMATION

CRESTOR rosuvastatin calcium tablets

Update on the Treatment of Hyperlipidemia

Achieve Your Best Health

Lipid- Lowering Medica0ons. Drugs for Med Students Presented by Eric Campbell & Jen Chen

Novel Therapeutic Strategies in Lipid Management: Lowering LDL C to Improve Patient Outcomes

Hyperlipidemia. Cardiovascular Disease. Is the leading cause of

See Important Reminder at the end of this policy for important regulatory and legal information.

Full prescribing information is available to doctors and pharmacists on request.

Lipid Guidelines Who, What, and How Low. Anita Ralstin, MS, CNP Next Step Health Consultant, LLC New Mexico Heart Institute

Pharmaceutical Help to Control Cholesterol

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Atorvastatin and upper arm pain

Supplement Table 2. Categorization of Statin Intensity Based on Potential Low-Density Lipoprotein Cholesterol Reduction

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ What GD-amlodipine/atorvastatin does: PART III: CONSUMER INFORMATION Pr GD-amlodipine/atorvastatin

CARDIOVASCULAR DISEASE WHAT IS IT? WHAT IS THE ROLE OF CHOLESTEROL? HOW CAN WE REDUCE RISK?

Learning Objectives. Patient Case

Pravastatin conversion to atorvastatin

Pharmacology Challenges: Managing Statin Myalgia

What do the guidelines say about combination therapy?

Lecture 36 Dyslipidemia Therapeutics Barry LIPIDS:

Managing Cholesterol

SOLVAY GROUP London Morning Meeting. June 26, 2009

A Review: Atherosclerosis & its treatment

Lipid Goals: Update on their Status

SESSION 5 2:15pm 3:45pm

Lipid Panel Management Refresher Course for the Family Physician

Medications for Treating Stroke

Dyslipidemia and HIV NORTHWEST AIDS EDUCATION AND TRAINING CENTER

This policy addresses the use of Juxtapid (lomitapide) for the treatment of treatment of homozygous familial hypercholesterolemia.

nicotinic acid 375mg, 500mg, 750mg, 1000mg modified release tablet (Niaspan ) No. (93/04) Merck

Review of guidelines for management of dyslipidemia in diabetic patients

7 KEYS. to Reduce Cholesterol. By Simeon Margolis, M.D., PH.D. & Roger S. Blumenthal, M.D. and the Editors of Johns Hopkins Health Alerts

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Heart Disease and Diabetes Teaching Module

Your Guide to Managing and Understanding Your Cholesterol Levels

2017 Cardiovascular Summit for Primary Care Thursday 30th & Friday 31st March Crowne Plaza, Dublin

See Important Reminder at the end of this policy for important regulatory and legal information.

It is the policy of health plans affiliated with PA Health & Wellness that Vytorin is medically necessary when the following criteria are met:

Repatha. Repatha (evolocumab) Description

Drug Class Review HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin

No relevant financial relationships

1.* Dosage. A. Adults

Conversion of crestor to lipitor

Coronary heart disease is the leading cause of death in

HEART HEALTH: A NEW ROLE FOR PROBIOTICS

Joshua Shepherd PA-C, MMS, MT (ASCP)

Antihyperlipidemic Drugs

Cardiovascular disease (CVD) causes one-third of deaths in

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI

SECTION 5: Conclusion RECOMMENDED RESOURCES REFERENCES: DISCLAIMER... 68

Pharmacy Drug Class Review

An update on lipidology and cardiovascular risk management. Lipids, Metabolism & Vascular Risk Section - Royal Society of Medicine

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

B. Patient has not reached the percentage reduction goal with statin therapy

New opportunities for targeting. multiple lipid pathways. Michel FARNIER, DIJON, FRANCE

Repatha. Repatha (evolocumab) Description

Transcription:

Bring this printout to your next doctor s appointment. It will help you and your doctor work together to set goals for treatment, evaluate the success of your treatment, and reduce your risk of side effects. I have high cholesterol, or I don t know my cholesterol levels which one best describes you? I have been diagnosed with high cholesterol. I don t know my cholesterol levels. Setting treatment goals and tracking your progress Setting goals will help you evaluate the success of your treatment. Ask your doctor to fill out the following chart at your visit. My treatment goals (ask your doctor to check all that apply and fill in levels) Test My targets My results LDL-C apob decrease at least 50% less than 2 mmol/l other: less than 0.80 g/l other: total cholesterol to HDL cholesterol ratio (TC: HDL-C ratio) less than 4.0 other: hs-crp less than 2.0 mg/l other: non-hdl cholesterol less than 3.5 mmol/l other: triglycerides less than 1.7 mmol/l other: 1 of 7

Test My targets My results apob:apoai ratio less than 0.80 other: Other goals (e.g., lose 10 lbs, quit Other goals (e.g., lose 10 lbs, quit Other goals (e.g., lose 10 lbs, quit Other goals (e.g., lose 10 lbs, quit Tracking my progress: The table above has a space for today s results. Use the Cholesterol Diary (you can find the diary under Health tools ) to track your progress over time. My treatments (check all that apply; if needed, ask your doctor for help) Medication I m using it I d like to learn more Statins Crestor (rosuvastatin); generic brands also Lescol/Lescol XL (fluvastatin) Lipitor (atorvastatin; also in combination with amlodipine under the brand name Caduet ); generic brands also Mevacor (lovastatin); generic brands also How long? How long? How long? How long? 2 of 7

Medication I m using it I d like to learn more Pravachol (pravastatin; also in combination with acetylsalicylic acid [ASA] under the brand name PravASA ); generic brands also Zocor (simvastatin); generic brands also How long? How long? Cholesterol absorption inhibitor Ezetrol (ezetimibe) How long? Resins Colestid (colestipol) cholestyramine (generic brands) Lodalis (colesevelam) How long? How long? How long? Fibrates Bezalip SR (bezafibrate); generic brands also How long? Lipidil Micro, Lipidil Supra, Lipidil EZ (fenofibrate); generic brands also How long? Lopid (gemfibrozil); generic brands also How long? Niacin (single and combination products) Advicor (niacin plus lovastatin) Niaspan, Niaspan FCT (extended-release niacin) Other niacin products (e.g., generic brands of slow-release and immediate-release niacin) I m not currently taking medications for my cholesterol. How long? How long? How long? 3 of 7

Other strategies to manage heart disease risk I m using it I d like to learn more Healthy diet How long? Exercise How long? Reaching/maintaining a healthy weight How long? Regular cholesterol testing How long? Managing my side effects My plan to manage side effects (ask your doctor to check all that apply to you and to fill in the blanks): Make sure I m on the most appropriate dose for my medication. Make sure I m taking my medication as directed and not accidentally taking extra doses. Know which side effects to watch for: Contact my doctor if I notice any side effects or changes that worry me. Other: 4 of 7

Other concerns about my cholesterol treatment (check all that apply to you) I m not sure if I m on the most appropriate cholesterol medication. I m not sure what my treatment goals are. I don t know if I am reaching my cholesterol targets. I m not sure if I really need my cholesterol medication. I m having trouble staying motivated to take my medication. I m not sure how to use my cholesterol medication. I m concerned that my cholesterol medication may interact with my other medications. I keep forgetting to take my cholesterol medication. I have some questions about my cholesterol treatment 1. Why is it important to lower my cholesterol? 2. How often should I have my cholesterol tested? 3. What do my cholesterol numbers mean? 4. Which numbers are important, and why? 5. What are my treatment goals? 6. Have my cholesterol levels improved? How close am I to reaching my treatment goals? 7. Am I on the most appropriate cholesterol medication? 8. Am I on the most appropriate dose of my medication? 5 of 7

I have some questions about my cholesterol treatment 9. Do I need to make any adjustments to my medication treatment to meet my treatment goals? 10. What else can I do to reach my cholesterol targets and reduce my risk of developing heart disease? For example, what lifestyle changes can I make (such as eating well, physical activity, weight control, quitting smoking, or drinking less)? Why are these lifestyle changes so important in? 11. Should I have any other tests (e.g., blood pressure, blood sugar testing, hs-crp testing) to assess my risk of developing heart disease and its complications? If a new treatment is recommended, I have some questions: 1. How do I use this treatment? 2. What are the benefits of this treatment? How much will this treatment help reduce my cholesterol and my risk of developing heart disease? 3. When can I expect it to start working? 4. What can I do if I m not sure whether my treatment is working? 5. What side effects should I expect? What should I do to reduce my risk, and what should I do if side effects occur? Other questions: 6 of 7

Notes: 7 of 7